​
Login / Signup
Rebecca Hommer
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 6
Top Topics
Open Label
Congenital Heart Disease
Phase Ii
Drug Administration
Top Venues
Neurology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Anne T Berg
,
Natasha N Ludwig
,
Mary Wojnaroski
,
Chere A T Chapman
,
Rebecca Hommer
,
Gabrielle Conecker
,
JayEtta Z Hecker
,
Jennepher Anne Downs
FDA Patient-Focused Drug Development Guidances.
Neurology
102 (1) (2023)
Anne T Berg
,
Natasha N Ludwig
,
Mary Wojnaroski
,
Chere A T Chapman
,
Rebecca Hommer
,
Gabrielle Conecker
,
JayEtta Z Hecker
,
Jennepher Anne Downs
FDA Patient-Focused Drug Development Guidances: Considerations for Trial Readiness in Rare Developmental and Epileptic Encephalopathies
Neurology
102 (1) (2023)
Anne T Berg
,
Natasha N Ludwig
,
Mary Wojnaroski
,
Chere A T Chapman
,
Rebecca Hommer
,
Gabrielle Conecker
,
JayEtta Z Hecker
,
Jennepher Anne Downs
FDA Patient-Focused Drug Development Guidances: Considerations for Trial Readiness in Rare Developmental and Epileptic Encephalopathies
Neurology
102 (1) (2023)
Anne T Berg
,
Natasha N Ludwig
,
Mary Wojnaroski
,
Chere A T Chapman
,
Rebecca Hommer
,
Gabrielle Conecker
,
JayEtta Z Hecker
,
Jennepher Anne Downs
FDA Patient-Focused Drug Development Guidances.
Neurology
102 (1) (2023)
Anne T Berg
,
Natasha N Ludwig
,
Mary Wojnaroski
,
Chere A T Chapman
,
Rebecca Hommer
,
Gabrielle Conecker
,
JayEtta Z Hecker
,
Jennepher Anne Downs
FDA Patient-Focused Drug Development Guidances: Considerations for Trial Readiness in Rare Developmental and Epileptic Encephalopathies
Neurology
102 (1) (2023)
Anne T Berg
,
Natasha N Ludwig
,
Mary Wojnaroski
,
Chere A T Chapman
,
Rebecca Hommer
,
Gabrielle Conecker
,
JayEtta Z Hecker
,
Jennepher Anne Downs
FDA Patient-Focused Drug Development Guidances: Considerations for Trial Readiness in Rare Developmental and Epileptic Encephalopathies
Neurology
102 (1) (2023)